AU7863900A - Il13 mutants - Google Patents

Il13 mutants Download PDF

Info

Publication number
AU7863900A
AU7863900A AU78639/00A AU7863900A AU7863900A AU 7863900 A AU7863900 A AU 7863900A AU 78639/00 A AU78639/00 A AU 78639/00A AU 7863900 A AU7863900 A AU 7863900A AU 7863900 A AU7863900 A AU 7863900A
Authority
AU
Australia
Prior art keywords
mutant
hill3
cells
cell
hil13
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU78639/00A
Other languages
English (en)
Inventor
Waldemar Debinski
Jeffrey P. Thompson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Penn State Research Foundation
Original Assignee
Penn State Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Penn State Research Foundation filed Critical Penn State Research Foundation
Publication of AU7863900A publication Critical patent/AU7863900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5437—IL-13
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
AU78639/00A 1999-10-06 2000-10-05 Il13 mutants Abandoned AU7863900A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15793499P 1999-10-06 1999-10-06
US60157934 1999-10-06
PCT/US2000/027567 WO2001025282A1 (fr) 1999-10-06 2000-10-05 Mutants il13

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2001288405A Division AU2001288405A1 (en) 1998-04-03 2001-08-24 Amino acid substitution mutants of interleukin 13

Publications (1)

Publication Number Publication Date
AU7863900A true AU7863900A (en) 2001-05-10

Family

ID=22565965

Family Applications (1)

Application Number Title Priority Date Filing Date
AU78639/00A Abandoned AU7863900A (en) 1999-10-06 2000-10-05 Il13 mutants

Country Status (5)

Country Link
EP (1) EP1222212A4 (fr)
JP (1) JP2003511019A (fr)
AU (1) AU7863900A (fr)
CA (1) CA2386248A1 (fr)
WO (1) WO2001025282A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010053371A1 (en) * 1999-01-07 2001-12-20 Waldemar Debinski Method for diagnosing, imaging, and treating tumors using restrictive receptor for interleukin 13
AU2001288405B8 (en) * 1998-04-03 2007-06-14 The Penn State Research Foundation Amino acid substitution mutants of interleukin 13
EP1141286B1 (fr) 1998-12-14 2006-10-18 Genetics Institute, LLC Chaine de recepteurs de cytokine
US7553487B2 (en) 1998-12-14 2009-06-30 Genetics Institute, Llc Method and compositions for treating asthma
EP1263785A2 (fr) * 1999-11-11 2002-12-11 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Modulation de l'activite de il-13 au moyen de molecules il-13 qui sont des antagonistes ou des agonistes de il-13
EA200400658A1 (ru) * 2001-11-09 2004-10-28 Неофарм, Инк. Способ лечения опухолей, экспрессирующих рецептор для ил-13 (варианты)
FI3718564T3 (fi) * 2003-12-23 2023-12-15 Genentech Inc Uusia anti-IL 13 -vasta-aineita ja niiden käyttöjä
AR049390A1 (es) 2004-06-09 2006-07-26 Wyeth Corp Anticuerpos contra la interleuquina-13 humana y usos de los mismos
US7501121B2 (en) 2004-06-17 2009-03-10 Wyeth IL-13 binding agents
US9072716B2 (en) 2005-04-15 2015-07-07 The United States of America, as represented by the Secretary Department of Health by Human Servies Methods of treating and preventing inflammatory bowel disease involving IL-13 and NKT cells
WO2013112871A1 (fr) 2012-01-27 2013-08-01 The Board Of Trustees Of The Leland Stanford Junior University Polypeptides d'il-13 thérapeutiques
CN116041551A (zh) 2013-09-24 2023-05-02 梅迪塞纳医疗股份有限公司 白介素-4受体结合融合蛋白及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696234A (en) * 1994-08-01 1997-12-09 Schering Corporation Muteins of mammalian cytokine interleukin-13
US5614191A (en) * 1995-03-15 1997-03-25 The United States Of America As Represented By The Department Of Health And Human Services IL-13 receptor specific chimeric proteins and uses thereof
US6296843B1 (en) * 1998-04-03 2001-10-02 The Penn State Research Foundation Mutagenized IL 13-based chimeric molecules
EP1206288B1 (fr) * 1999-08-02 2007-01-10 The Regents Of The University Of Michigan Effecteurs radiatifs cibles exempts de fibres

Also Published As

Publication number Publication date
EP1222212A1 (fr) 2002-07-17
WO2001025282A1 (fr) 2001-04-12
JP2003511019A (ja) 2003-03-25
EP1222212A4 (fr) 2005-05-04
CA2386248A1 (fr) 2001-04-12

Similar Documents

Publication Publication Date Title
US6576232B1 (en) IL13 mutants
JP4202417B2 (ja) Ｉｌ−１３受容体特異的キメラタンパク質およびその用途
US6428788B1 (en) Compositions and methods for specifically targeting tumors
US6296843B1 (en) Mutagenized IL 13-based chimeric molecules
US6518061B1 (en) IL-13 receptor specific chimeric proteins and uses thereof
EP0754192B1 (fr) Ligands et molecules chimeriques a permutation circulaire
US7750136B2 (en) Modified bouganin proteins, cytotoxins and methods and uses thereof
US6884603B2 (en) Nucleic acids encoding IL13 mutants
AU2001288405B2 (en) Amino acid substitution mutants of interleukin 13
AU7863900A (en) Il13 mutants
US6630576B2 (en) Amino acid substitution mutants of interleukin 13
US20030129132A1 (en) IL-13 receptor specific chimeric proteins & uses thereof
AU2001288405A1 (en) Amino acid substitution mutants of interleukin 13

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period